Disclosed herein are compositions and methods for treating a psychiatricdisorderor symptoms thereof in a patient. The compositions comprise a compound thatmodulatesKCNQ (Kv7) potassium channel activity and the methods include administering aneffective amount of the compound that modulates KCNQ (Kv7) potassium channelactivity.